Literature DB >> 19631237

Neonatal lipopolysaccharide induces pathological changes in parvalbumin immunoreactivity in the hippocampus of the rat.

Trisha A Jenkins1, Michael K Harte, Gillian Stenson, Gavin P Reynolds.   

Abstract

Early exposure to infection is known to affect brain development and has been linked to an increased risk for schizophrenia. The present study aimed to determine whether neonatal infection produced long-term disruptions in behaviour and pathology that might provide a parallel with that observed in schizophrenia. Rats were administered lipopolysaccharide (LPS; 500 microg/kg i.p.) on postnatal day 7 and 9. Locomotor activity and object recognition memory were tested at day 35 and day 70. LPS animals were observed to be less active at adulthood as measured by locomotor activity. With regards to object recognition memory, LPS administration produced no early impairment in task performance, however, at day 70 LPS animals spent significantly less time exploring the novel object than control animals. Analysis of brains showed a reduction in expression of parvalbumin immunoreactive neurons in the hippocampus of LPS animals with significant reductions selectively localised to the CA1-CA3 region, and not the dentate gyrus. No changes were observed in prefrontal cortex. These results show that neonatal LPS results in pathophysiological brain changes in hippocampal CA1-CA3 subregions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631237     DOI: 10.1016/j.bbr.2009.07.014

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  23 in total

Review 1.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

Review 2.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

Review 3.  Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

Authors:  Kim Q Do; Michel Cuenod; Takao K Hensch
Journal:  Schizophr Bull       Date:  2015-06-01       Impact factor: 9.306

Review 4.  How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.

Authors:  Xin Wang; António Pinto-Duarte; Terrence J Sejnowski; M Margarita Behrens
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

Review 5.  Models of neurodevelopmental abnormalities in schizophrenia.

Authors:  Susan B Powell
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 6.  Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia.

Authors:  Susan B Powell; Terrence J Sejnowski; M Margarita Behrens
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

Review 7.  Social Origins of Developmental Risk for Mental and Physical Illness.

Authors:  Judy L Cameron; Kathie L Eagleson; Nathan A Fox; Takao K Hensch; Pat Levitt
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

Review 8.  Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?

Authors:  P Steullet; J H Cabungcal; A Monin; D Dwir; P O'Donnell; M Cuenod; K Q Do
Journal:  Schizophr Res       Date:  2014-07-05       Impact factor: 4.939

9.  Effects of centrally administered etanercept on behavior, microglia, and astrocytes in mice following a peripheral immune challenge.

Authors:  Marie Lou Camara; Frances Corrigan; Emily J Jaehne; Magdalene C Jawahar; Helen Anscomb; Bernhard T Baune
Journal:  Neuropsychopharmacology       Date:  2014-08-08       Impact factor: 7.853

10.  Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats.

Authors:  Carlos Feleder; Kuei Yuan Tseng; Gwendolyn G Calhoon; Patricio O'Donnell
Journal:  Biol Psychiatry       Date:  2009-11-14       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.